Clinical Trials Logo

Pleuropneumonia clinical trials

View clinical trials related to Pleuropneumonia.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT05111002 Terminated - Clinical trials for Mycoplasma Genitalium Infection

Lefamulin for M. Genitalium Treatment Failures

Start date: April 22, 2022
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this drug study is to find out whether the antibiotic lefamulin (trade name Xenleta) will cure Mycoplasma genitalium infections that have not been cured by prior antibiotics while finding out whether it is more effective if the antibiotic doxycycline is taken first.

NCT ID: NCT03910907 Terminated - Clinical trials for Mycoplasma Genitalium Infection

Comparison of Standard of Care Guidelines for Mycoplasma Genitalium Infections Among Men With Non-gonococcal Urethritis

Start date: November 19, 2019
Phase:
Study type: Observational

The purpose of this protocol is to determine the difference in clearance of Mycoplasma genitalium (MG) when using the Australian management protocol versus the current Centers of Disease Control (CDC) treatment guidelines for US standard of care (SOC), to determine the proportion of men from the Deep South, with NGU attributable to MG, and to determine the proportion of MG cases that harbor the macrolide-resistance associated with mutation.

NCT ID: NCT01217099 Terminated - Clinical trials for Refractory Mycoplasma Pneumoniae Pneumonia

Methylprednisolone Pulse Macrolide Therapy for Refractory Mycoplasma Pneumoniae Pneumonia in Children

MPP
Start date: May 2007
Phase: N/A
Study type: Interventional

The purpose of this study is planned to investigate whether small doses of methylprednisolone pulse macrolide therapy can relieve symptoms,chest X-rays faster than macrolide alone therapy for refractory mycoplasma pneumoniae pneumonia(MPP) .